Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4630)
All Articles published online
|
Publishing Process of This Article
|
Jun 26, 2021 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Adhoute X, Larrey E, Anty R, Chevallier P, Penaranda G, Tran A, Bronowicki JP, Raoul JL, Castellani P, Perrier H, Bayle O, Monnet O, Pol B, Bourliere M. Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results. World J Clin Cases 2021; 9(18): 4559-4572 [PMID: 34222423 DOI: 10.12998/wjcc.v9.i18.4559] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i18/4559.htm |
| Number | Citing Articles |
| 1 |
Na Zhang, Xiao-Feng He, Xiang-Ke Niu. Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis. World Journal of Methodology 2023; 13(4): 345-358 doi: 10.5662/wjm.v13.i4.345
Abstract(547) |
Core Tip(483) |
Full Article(HTML)(1267)
|
Full Article with Cover (PDF)-36372K(116)
|
Full Article (Word)-8711K(42)
|
Audio-5356K(7)
|
Peer-Review Report-256K(63)
|
Answering Reviewers-356K(62)
|
Supplementary Material-341K(69)
|
Full Article (PDF)-36160K(121)
|
Full Article (XML)-129K(56)
|
Times Cited (1)
|
Total Visits (4912)
|
Open
|
| 2 |
Xiang-Ke Niu, Xiao-Feng He. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma. Journal of Personalized Medicine 2022; 12(9): 1375 doi: 10.3390/jpm12091375
|
| 3 |
Apichat Kaewdech, Pimsiri Sripongpun, Suraphon Assawasuwannakit, Panu Wetwittayakhlang, Sawangpong Jandee, Naichaya Chamroonkul, Teerha Piratvisuth. FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1077842
|
| 4 |
Lukas Müller, Felix Hahn, Timo Alexander Auer, Uli Fehrenbach, Bernhard Gebauer, Johannes Haubold, Sebastian Zensen, Moon-Sung Kim, Michel Eisenblätter, Thierno D. Diallo, Dominik Bettinger, Verena Steinle, De-Hua Chang, David Zopfs, Daniel Pinto dos Santos, Roman Kloeckner. Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.850454
|